Savaria Corporation

Savaria Corporation provides accessibility solutions for the elderly and physically challenged people in Canada, the United States, Europe, and internationally. The company operates in three segments: Accessibility, Patient Care, and Adapted Vehicles. The Accessibility segment designs, manufactures, distributes, and installs accessibility products, such as stairlifts for straight and curved stairs, vertical and inclined wheelchair platform lifts for commercial and residential applications, and accessibility and home elevators. The Patient Care segment manufactures and distributes therapeutic support surfaces and other pressure management products for the medical and medical beds, as well as offers medical equipment and solutions for the safe handling of patients. The Adapted Vehicles segment offers distributing vehicles for people with mobility challenges for personal or commercial use. The company sells its products through dealers and by direct stores to end-user customers. Savaria Corporation was founded in 1979 and is headquartered in Laval, Canada.

Savaria Corporation trades as SIS.TO on TSX. The company is classified in Industrials / Industrial - Machinery and reports in CAD.

The current profile places the business in Industrial - Machinery. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows $913.53M of revenue and $68.77M of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Savaria Corporation can be compared against peers such as Andlauer Healthcare Group Inc., Black Diamond Group Limited, Bird Construction Inc., Ballard Power Systems Inc., Cargojet Inc., Magellan Aerospace Corporation.

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $2.09B, beta of 0.98, and return on equity of +10.7%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

SIS.TO currently shows total debt of $205.91M and beta of 0.98. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.savaria.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.